APRIL 2018 New patents

APRIL 2018

New patents,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	EP-03305769	ROXADUSTAT	ZENTIVA	ANEMIA
2	EP-03305799	OBETICHOLIC ACID	LUPIN	P rimary biliary cirrhosis
3	WO-2018067945	VALBENAZINE	ASSIA TEVA	Huntingtons chorea; Tardive dyskinesia; Tourette syndrome
4	WO-2018067805	SOTAGLIFLOZIN	TEVA	Diabetes mellitus
5	WO-2018066004	DORZOLAMIDE	INDOCO	Glaucoma; Ocular hypertension
6	WO-2018065999	PALBOCICLIB	MYLAN	Breast tumor
7	WO-2018065924	BINIMETINIB SELUMETINIB	SUN	Cancer; Melanoma
8	WO-2018064797	ACALABRUTINIB	SOLIPHARMA	Autoimmune disease; Inflammatory disease; Lymphoma
9

 ,

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2018064585	ODALASVIR	ACHILLION	Hepatitis C virus infection
2	WO-2018062799	ASIVATREP	AMOREPACIFIC	Asthma; Chronic obstructive pulmonary disease; Dermatological disease; Inflammatory bowel disease; Inflammatory disease; Irritable bowel syndrome
3	WO-2018061034	APREMILAST	SUN	Arthritis
4	WO-2018060916	BREXPIPRAZOLE	ALEMBIC	Major depressive disorder; Schizophrenia
5	WO-2018060781	LACOSAMIDE	UNICHEM	Epilepsy; Partial seizure
6	WO-2018059914	GADOBUTROL	BAYER	Artery disease; Brain tumor; Breast tumor; Central nervous system disease; Vascular disease
7	WO-2018059556	VOROLANIB	BETTA	Gastrointestinal stromal tumor; Renal cell carcinoma
8	WO-2018059531	TOZADENANT	CRYSTAL	Alzheimers disease; Anxiety disorder; Attention deficit hyperactivity disorder; Depression; Huntingtons chorea; Parkinsons disease; Schizophrenia
9	WO-2018059288	MACITENTAN	SEASONS	Idiopathic pulmonary arterial hypertension
10	WO-2018058296	AZELIRAGON	SOLIPHARMA	Alzheimers disease